What they do
Pharos iBio develops an AI-driven drug discovery platform, Chemiverse, which manages over 200 million biological data points. Biotechnology companies and clinical researchers use the platform to predict clinical toxicity, discover novel indications, and optimize target compounds.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- AI drug discovery
- Product type
- Platform software
- Stage
- Public
- Headquarters
- Anyang, South Korea
- Region
- Asia-Pacific
- Founded
- 2014
- Total funding
- $20M raised
Notable investors: Korea Investment Partners, DSC Investment, KDB Bank.